BEACON EMR HIPAA Disclaimer Site Map Social Media
BayCare Health System
Community Benefit Financial Assistance Policy Quality Report Card Health Library News Doctor Connect Find Us
Services Hospitals Find A Doctor Classes & Events About Us Careers Contact Us Get E-Newsletter
UroVysion by FISH
 Back  Back


May We Help You?
 

Call 1-877-692-2922
Monday-Friday, 8am to 5pm

Persons with hearing and speech disabilities can reach the above number through TDD and other specialized equipment by calling the Florida Relay Service at 711.

Contact Us
Send 
e-mail
Search jobs


Decrease (-) Restore Default Increase (+) Font Size
Print    Email

UroVysion by FISH

Test name:
UroVysion (CEP 3/7/17 and 9p21)

Order name:
UroVysion by FISH request

Specimen requirements:
Urine, bladder washing, urethral washing

Minimum volume:
50mL of neat urine. Any volume of bladder and urethral washing will be attempted if cells are present.

Storage and stability information:
Refrigerated. Transport to lab within 1 day of collection.

Test performed:
Twice per week

Methodology:
Fluorescence in situ hybridization

Reference range:
See lab report

Clinical significance:
The UroVysion assay is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results from this assay are intended for use, in conjunction with current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria, and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.

CPT codes:
88368 x 4

 


Serving The Tampa Bay Area © Copyright 2014 BayCare Health System